Gilead Sciences, Inc.
GILD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882095
In the last 90 days, Gilead Sciences, Inc. insiders filed 0 open-market purchases and 11 sales; 2,293 institutions reported holding it in 13F filings for Q2 2026, worth $140.5B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Gilead Sciences, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1,887
- +195 vs. Q3 2024
- Shares held
- 1.06B
- +23.3M (+2.2%) vs. Q3 2024
- Total value
- $98.2B
- +$10.8B (+12.3%) vs. Q3 2024
- New holders
- 290
- 652 more added
- Sold out
- 95
- 720 more reduced
30 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GILD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2,293 | $140.5B |
| Q1 2026 | 2,330 | $151.6B |
| Q4 2025 | 2,224 | $137.2B |
| Q3 2025 | 2,033 | $117.3B |
| Q2 2025 | 2,024 | $119.2B |
| Q1 2025 | 2,018 | $119.1B |
| Q4 2024 | 1,887 | $98.2B |
| Q3 2024 | 1,722 | $87.7B |
| Q2 2024 | 1,683 | $71.3B |
| Q1 2024 | 1,723 | $76.2B |
| Q4 2023 | 1,781 | $84.9B |
| Q3 2023 | 1,688 | $78.1B |
| Q2 2023 | 1,705 | $80.5B |
| Q1 2023 | 1,741 | $86.1B |
| Q4 2022 | 1,771 | $88.5B |
| Q3 2022 | 1,604 | $62.2B |
| Q2 2022 | 1,606 | $61.7B |
| Q1 2022 | 1,602 | $59.2B |
| Q4 2021 | 1,685 | $73.4B |
| Q3 2021 | 1,568 | $70.1B |
| Q2 2021 | 1,550 | $68.5B |
| Q1 2021 | 1,572 | $63.4B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Gilead Sciences, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northwest Investment Counselors, LLC | – | – | – | – | Not filed |
| FinTrust Capital Advisors, LLC | – | – | – | – | Not filed |
| Abich Financial Wealth Management LLC | – | – | – | – | Not filed |
| Alpine Bank Wealth Management | – | – | – | – | Not filed |
| Naples Money Management LLC | – | – | – | – | Not filed |
| First Personal Financial Services | – | – | – | – | Not filed |
| VitalStone Financial, LLC | – | – | – | – | Not filed |
| WFA of San Diego, LLC | – | – | – | – | Not filed |
| Peterson Financial Group, Inc. | – | – | – | – | Not filed |
| Planning Capital Management Corp | – | – | – | – | Not filed |
| ClariVest Asset Management LLC | – | – | – | – | Not filed |
| Carmichael Hill & Associates, Inc. | – | – | – | – | Not filed |